|
Martin Dieck, President & CEO. Prior to joining Nfocus, Martin was President and CEO of CardioVasc, a manufacturer of medical implants with biomimetic properties that promote rapid healing and resist rejection by bodily defenses. Previously he was Co-Founder, President and CEO of Concentric Medical, which was the first company to receive approval from the US government to treat ischemic stroke. Martin also served as senior executive at a medical incubator where he evaluated early-stage medical device opportunities and participated in the formation of four companies. Earlier, Martin was also a co-founder of Micro Interventional Systems, an early interventional neuroradiology start-up, which was acquired in 1995. In addition to his operational and deal- evaluation expertise, Martin is also an inventor with numerous issued and pending patents. Martin received his B.A. in Biological Sciences from Willamette University and M.B.A. from the University of California at Berkeley. | 